This fallen FTSE 250 darling could be the best share for me to buy now

Jon Smith outlines how the start of a transformation at a beaten-down FTSE 250 company could make it a great time for him to buy.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Image source: Getty Images

Over the past three years, the St James’s Place (LSE:STJ) share price has halved in value. In fact in Q2, it hit the lowest level in over a decade. Yet the FTSE 250 firm’s managed to rally 32% in just the past three months, with some indications that the worst is in the rear view mirror. Here’s why it could be a smart purchase for me right now.

Taking action

One catalyst that’s helped the stock to rally was the half-year results released at the end of July. It was the first real opportunity for the management team to express how they were planning on turning the business around.

In the report, it spoke of “an addressable cost base reduction programme”. This is anticipated to give cumulative net savings of around £500m through to 2030. The results also spoke about taking a chunk of these savings to invest for “strategic initiatives and underpinning long-term growth ambitions.”

These comments clearly helped to give investors more optimism about the future. Part of the issue for some firms is that the management team doesn’t accept there’s a problem. Therefore, things never change. Yet the fact that action’s being taken shows that the falling share price can be addressed.

Loyal client base

Another factor that makes me want to buy the stock is the type of clients the firm has. Despite all the problems over the past few years, the funds under management hit a new record at £181.9bn in H1 2024. This is up from the £168.2bn from the end of December 2023.

The more money from clients the company looks after, the more profitable it can become. Sure, the client advisers have to sell financial products in order to turn that money into revenue. But I’m impressed at how the company’s retained a lot of clients through a difficult period. Not only this, but it’s actually increased the funds being managed.

This shows me that clients do like the offer. Otherwise they would quickly move money elsewhere.

Caution needed

Despite these positive points, I do need to be mindful of the issues that got the company in a pickle in the first place. One of the major ones was the £426m compensation pot set up earlier this year for historical overcharging of client fees.

The fact that the systems and policies didn’t pick up on the correct fees that should have been charged is worrying. Of course, the firm’s addressing this issue. But it’s embarrassing that something like this was happening internally without it being picked up for a long time.

I’m seriously thinking about buying the stock for long-term gains and feel it represents one of the best potential growth options right now.

Jon Smith has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Growth Shares

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Are investors taking a big gamble chasing Rolls-Royce shares higher and higher?

With Rolls-Royce shares having fallen back from their peak, the temptation to see this as a buying opportunity must be…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Growth Shares

Why high oil prices could be good news for Lloyds shares

Jon Smith talks through the implications of elevated oil prices and translates that through to the potential impact on Lloyds'…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

Shell’s £33+ share price is near an all-time high, so why am I going to buy more as soon as possible?

Shell's strong cash generation and improving growth drivers contrast with a share price well below my valuation, suggesting major long‑term…

Read more »

Female student sitting at the steps and using laptop
Growth Shares

Down 17% in a month, this household FTSE 250 stock looks cheap

Jon Smith acknowledges the recent market sell-off but points out a FTSE 250 stock that he believes offers a long-term…

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

Are investors running scared of Babcock and BAE Systems shares?

BAE Systems shares have had a brilliant run, and other UK defence stocks have been flying too. But Harvey Jones…

Read more »

Mature black woman at home texting on her cell phone while sitting on the couch
Investing Articles

As the FTSE 100 falls, savvy investors are looking for stocks to buy for the rebound

Many FTSE stocks have now fallen 10% or more from their 2026 highs. For long-term investors, exciting opportunities are emerging.

Read more »

Abstract bull climbing indicators on stock chart
Growth Shares

3 growth shares for an ISA that have beaten the FTSE 100 for the past 5 years

Jon Smith points out several growth shares that have outperformed the broader market over a long period of time, with…

Read more »

Friends at the bay near the village of Diabaig on the side of Loch Torridon in Wester Ross, Scotland. They are taking a break from their bike ride to relax and chat. They are laughing together.
Investing Articles

2 UK stocks to consider buying as Mounjaro and Wegovy take off

Weight-loss drugs like Mounjaro are surging in popularity, making the following pair interesting stocks to think about buying today.

Read more »